Lung Cancer
📧 Sign up to get email alerts when something new happens for Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: Study of Vinorelbine and Cisplatin as Induction Therapy With Radiotherapy in Patients With Unresectable NSCLC [Phase 2]
A phase 2 trial assessing induction therapy with vinorelbine and cisplatin followed by radiotherapy in patients with unresectable lung cance…
-
CLINICAL_TRIALS trial_result · 2024-01-09Clinical Trial Update: High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer [EARLY_Phase 1]
Early-phase trial of a high-dose vitamin A compound in participants with resectable non-small cell lung cancer was terminated; results poste…
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: Trial of Tumor Vaccine Used for Adjuvant Therapy in Post Radical Operation Patients With Lung Cancer [Phase 1, Phase 2]
Clinical trial update on a tumor vaccine used as adjuvant therapy after radical operation in lung cancer patients, spanning Phase 1 and Phas…
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: Risk Communication in African American Smokers [NA]
Clinical trial update on risk communication in African American smokers related to lung cancer; study completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-11-02Clinical Trial Update: The Lung Screening, Tobacco and Health Project [Phase 3]
Phase 3 clinical trial update on a project examining lung screening and tobacco-related health outcomes; study completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: Evaluating the Combination of MK-3475 and Sterotactic Body Radiotherapy in Patients With Metastatic Melanoma or NSCLC [Phase 1, Phase 2]
Phase 1/2 trial evaluating MK-3475 (pembrolizumab) in combination with stereotactic body radiotherapy in patients with metastatic melanoma o…
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: Wedge Resection for Ground-glass Opacity-featured Lung Cancer (ECTOP-1020) [Phase 3]
Phase 3 clinical trial update for wedge resection in lung cancer with ground-glass opacity features; not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2023-10-24Clinical Trial Update: Performance and Safety of Biology-Guided Radiotherapy Using the RefleXion Medical Radiotherapy System (BIOGUIDE-X) [NA]
Completed clinical trial evaluating performance and safety of biology-guided radiotherapy with the RefleXion Radiotherapy System (BIOGUIDE-X…
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers [NA]
This completed clinical trial evaluated palliative lattice stereotactic body radiotherapy (SBRT) for patients with sarcoma and other thoraci…
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare® [NA]
A completed clinical trial evaluating remote monitoring of patient-reported outcomes in lung cancer patients using Moovcare.
-
CLINICAL_TRIALS trial_result · 2023-10-05Clinical Trial Update: Piloting Pathways With Lung Cancer Patients [NA]
Clinical trial update for a study involving metastatic lung cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action [Phase 4]
A Phase 4 clinical trial investigates how using different anesthetics affects prognosis in primary tumors and explores the mechanism of acti…
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Sitravatinib as Maintenance Therapy for ES-SCLC [Phase 2]
Phase 2 trial evaluating tislelizumab with sitravatinib as maintenance therapy for extensive-stage small cell lung cancer (ES-SCLC).
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: Sintilimab Combined With Anlotinib in Advanced NSCLC With EGFR Uncommon Mutations [Phase 2]
Phase 2 clinical trial evaluating the combination of sintilimab and anlotinib in advanced non-small cell lung cancer with EGFR uncommon muta…
-
CLINICAL_TRIALS trial_result · 2023-09-11Clinical Trial Update: Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018) [Phase 3]
Phase 3 clinical trial investigating selective lymph node dissection for early-stage invasive non-small cell lung cancer (cT1N0M0, CTR>0.5) …
-
CLINICAL_TRIALS trial_result · 2023-08-29Clinical Trial Update: Radiotherapy Combined With Almonertinib for Stage III EGFR-Mutated Lung Cancer [Phase 2, Phase 3]
A clinical trial update exploring radiotherapy in combination with almonertinib for stage III EGFR-mutated lung cancer (Phase 2/Phase 3).
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene [Phase 1, Phase 2]
Phase 1/2 clinical trial studying A166 in patients with various HER2-expressing or HER2-amplified cancers has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Adjuvant Chemotherapy for High Risk Stage I Lung Adenocarcinoma [Phase 2, Phase 3]
A clinical trial update on adjuvant chemotherapy for high-risk stage I lung adenocarcinoma across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2023-07-18Clinical Trial Update: LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial investigating LMB-100 followed by pembrolizumab in adults with mesothelin-expressing non-squamous non-small cell lung cancer; …
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating FLT3 ligand and CD40 agonist antibody with stereotactic radiotherapy for lung cancer (non-small cell/non…
-
CLINICAL_TRIALS trial_result · 2023-07-13Clinical Trial Update: A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) [Phase 1, Phase 2]
Clinical trial update for KVA12123 as a standalone and in combination with pembrolizumab in advanced solid tumors; current status is unknown…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Plasmodium Immunotherapy for Lung Cancer [Phase 1, Phase 2]
A clinical trial update on a plasmodium immunotherapy approach for lung cancer, currently in Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers [Phase 4]
Phase 4 trial investigating safety of nivolumab in combination with ipilimumab for advanced cancers; completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial comparing two combination chemotherapy regimens for treating lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy [Phase 2]
Phase 2 trial update for ADMIRAL evaluating adaptive mediastinal radiation with chemo-immunotherapy in locally advanced non-small cell lung …